ACELRX PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 30, 2011

Attached files

file filename
10-K - ANNUAL REPORT ON FORM 10-K - ACELRX PHARMACEUTICALS INCd10k.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - ACELRX PHARMACEUTICALS INCdex312.htm
EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - ACELRX PHARMACEUTICALS INCdex321.htm
EX-10.5 - FORMS OF STOCK OPTION GRANT NOTICE, STOCK OPTION EXERCISE NOTICE AND STOCK... - ACELRX PHARMACEUTICALS INCdex105.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - ACELRX PHARMACEUTICALS INCdex311.htm
EX-10.3 - FORMS OF NOTICE OF GRANT OF STOCK OPTION, STOP OPTION AGREEMENT AND STOCK OPTION - ACELRX PHARMACEUTICALS INCdex103.htm
EX-10.6 - FORM OF RESTRICTED STOCK UNIT GRANT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT - ACELRX PHARMACEUTICALS INCdex106.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2006 Stock Plan, 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan of AcelRx Pharmaceuticals, Inc. of our report dated March 30, 2011, with respect to the financial statements of AcelRx Pharmaceuticals, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2010.

/s/ Ernst & Young LLP

Palo Alto, California

March 30, 2011

ACELRX PHARMACEUTICALS INC Reports